|
gptkbp:instance_of
|
gptkb:pharmaceuticals
|
|
gptkbp:approves
|
gptkb:1980s
|
|
gptkbp:atccode
|
B01 AC06
|
|
gptkbp:available_on
|
gptkb:pharmaceuticals
|
|
gptkbp:brand
|
gptkb:Bayer_Aspirin
|
|
gptkbp:chemical_formula
|
C9 H8 O4
|
|
gptkbp:clinical_trial
|
pain management studies
cancer prevention studies
cardiovascular health studies
|
|
gptkbp:contraindication
|
severe liver disease
allergy to aspirin
severe kidney disease
active peptic ulcer
|
|
gptkbp:dosage_form
|
gptkb:tablet
|
|
gptkbp:formulation
|
gptkb:liquid
enteric-coated
chewable tablet
effervescent tablet
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Bayer Low Dose Aspirin
|
|
gptkbp:ingredients
|
gptkb:acetylsalicylic_acid
|
|
gptkbp:interacts_with
|
gptkb:methotrexate
gptkb:warfarin
SSRIs
other NSAIDs
|
|
gptkbp:legal_status
|
OTC
|
|
gptkbp:manufacturer
|
gptkb:Bayer_AG
|
|
gptkbp:marketed_as
|
gptkb:Europe
gptkb:Australia
gptkb:Canada
gptkb:United_States
|
|
gptkbp:packaging
|
gptkb:bottle
blister pack
|
|
gptkbp:recommendation
|
consult healthcare provider before use
daily low-dose for certain patients
not recommended for children with viral infections
|
|
gptkbp:route_of_administration
|
oral
|
|
gptkbp:shelf_life
|
varies by packaging
|
|
gptkbp:side_effect
|
nausea
gastrointestinal bleeding
stomach upset
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:strength
|
81 mg
|
|
gptkbp:used_for
|
pain relief
cardiovascular disease prevention
anti-inflammatory purposes
|
|
gptkbp:bfsParent
|
gptkb:Bayer_Aspirin
|
|
gptkbp:bfsLayer
|
5
|